Cargando…
Update on the Treatment of Diabetic Retinopathy
Retinopathy is the most feared complication of diabetes, compromising quality of life in most sufferers. Almost all patients with type 1 diabetes will develop retinopathy over a 15- to 20-year period, and approximately 20–30% will advance to the blinding stage of the disease[1]. Greater than 60% of...
Autores principales: | Wilkinson-Berka, Jennifer L., Miller, Antonia G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848621/ https://www.ncbi.nlm.nih.gov/pubmed/18264628 http://dx.doi.org/10.1100/tsw.2008.25 |
Ejemplares similares
-
(Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?
por: Wilkinson-Berka, Jennifer L., et al.
Publicado: (2009) -
Diabetic retinopathy: An update
por: Singh, Ramandeep, et al.
Publicado: (2008) -
Update on genetics and diabetic retinopathy
por: Hampton, Blake M, et al.
Publicado: (2015) -
FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy
por: Deliyanti, Devy, et al.
Publicado: (2015) -
Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy
por: Tomita, Yohei, et al.
Publicado: (2021)